| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
Cloprostenol targets the prostaglandin F (PGF) receptor (FP receptor). As a PGF2α analogue, it binds to the FP receptor and activates signaling pathways that lead to luteolysis (regression of the corpus luteum). This results in the termination of pregnancy and synchronization of estrus in animals. It is used as a veterinary drug for reproductive management.
|
|---|---|
| ln Vitro |
In vitro, cloprostenol acts as a PGF2α analogue and FP receptor agonist. It activates FP receptor signaling pathways. Its specific in vitro activities are related to its luteolytic and reproductive effects. It is used in research on prostaglandin signaling and reproductive physiology.
|
| ln Vivo |
In vivo, cloprostenol is used in animals for terminating pregnancy and inducing luteolysis. It is used for the synchronization of estrus in cattle. It is a synthetic prostaglandin F2alpha analog. Detailed in vivo efficacy and safety data are available from veterinary studies.
|
| Enzyme Assay |
Cell-free FP receptor binding assays for cloprostenol use membrane preparations from cells expressing FP receptors. Radioligand binding is performed with a labeled PGF2α ligand (e.g., [3H]PGF2α). Cloprostenol is tested at concentrations ranging from 0.1 nM to 100 µM. Non-specific binding is determined using an excess of unlabeled PGF2α. IC50 and Ki values are calculated from competition curves.
|
| Cell Assay |
In vitro cellular assays for cloprostenol use cells expressing FP receptors. Cells are treated with cloprostenol at concentrations of 0.1-1000 nM for 1-24 hours. Receptor activation is assessed by measuring calcium flux using fluorescent calcium indicators or by measuring inositol phosphate accumulation. Luteal cell cultures are used to assess progesterone production and cell viability.
|
| Animal Protocol |
In vivo animal experiments for cloprostenol use cattle, horses, or other livestock for reproductive management. Cloprostenol is administered by intramuscular injection at doses of 0.1-1 mg. Endpoints include estrus synchronization, pregnancy termination, and luteolysis assessment by progesterone level measurement. Veterinary studies assess efficacy and safety.
|
| References |
[1]. Intra-vesicle administration of D-cloprostenol for induction of abortion in mid-gestation bitches. Anim Reprod Sci. 2008 Jun;106(1-2):133-42.
|
| Additional Infomation |
Cloprostenol is a prostaglandin analogue, a synthetic prostaglandin F2α analog. This compound has luteolytic activity and is used for estrus synchronization in cattle. See also: Cloprostenol sodium (in salt form).
|
| Molecular Formula |
C22H29CLO6
|
|---|---|
| Molecular Weight |
424.92
|
| Exact Mass |
424.165
|
| Elemental Analysis |
C, 62.19; H, 6.88; Cl, 8.34; O, 22.59
|
| CAS # |
40665-92-7
|
| Related CAS # |
55028-72-3 (mono-hydrochloride salt)
|
| PubChem CID |
5311053
|
| Appearance |
White to off-white solid
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
628.0±55.0 °C at 760 mmHg
|
| Flash Point |
333.6±31.5 °C
|
| Vapour Pressure |
0.0±1.9 mmHg at 25°C
|
| Index of Refraction |
1.623
|
| LogP |
2.31
|
| tPSA |
107.22
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
11
|
| Heavy Atom Count |
29
|
| Complexity |
551
|
| Defined Atom Stereocenter Count |
5
|
| SMILES |
C(=C/C[C@@H]1[C@@H](/C=C/[C@H](COC2=CC=CC(=C2)Cl)O)[C@@H](C[C@@H]1O)O)/CCCC(=O)O
|
| InChi Key |
VJGGHXVGBSZVMZ-QIZQQNKQSA-N
|
| InChi Code |
InChI=1S/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1
|
| Chemical Name |
(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.3534 mL | 11.7669 mL | 23.5338 mL | |
| 5 mM | 0.4707 mL | 2.3534 mL | 4.7068 mL | |
| 10 mM | 0.2353 mL | 1.1767 mL | 2.3534 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.